Novavax
NVAX
#5391
Rank
ยฃ1.04 B
Marketcap
ยฃ6.45
Share price
11.87%
Change (1 day)
-8.41%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): ยฃ0.28 Billion

According to Novavax's latest financial reports the company's current earnings are ยฃ1.02 Billion. In 2024 the company made an earning of -ยฃ0.12 Billion, an increase over its 2023 earnings that were of -ยฃ0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.28 B-348.73%
2024 -ยฃ0.12 Billion-70.39%
2023 -ยฃ0.4 Billion-16.59%
2022 -ยฃ0.48 Billion-62.58%
2021 -ยฃ1.26 Billion320.54%
2020 -ยฃ0.3 Billion234.22%
2019 -ยฃ89.6 Million-30.17%
2018 -ยฃ0.13 Billion1.69%
2017 -ยฃ0.13 Billion-36.44%
2016 -ยฃ0.2 Billion70.4%
2015 -ยฃ0.12 Billion89.27%
2014 -ยฃ61.56 Million59.83%
2013 -ยฃ38.52 Million81.9%
2012 -ยฃ21.18 Million50.33%
2011 -ยฃ14.09 Million
2009 -ยฃ27.8 Million8.8%
2008 -ยฃ25.55 Million18.01%
2007 -ยฃ21.65 Million18.33%
2006 -ยฃ18.3 Million168.31%
2005 -ยฃ6.82 Million-62.51%
2004 -ยฃ18.19 Million52.4%
2003 -ยฃ11.94 Million-28.21%
2002 -ยฃ16.63 Million
2000 -ยฃ9.48 Million177%
1999 -ยฃ3.43 Million-11.54%
1998 -ยฃ3.87 Million10.64%
1997 -ยฃ3.5 Million-9.62%
1996 -ยฃ3.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
ยฃ15.36 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-ยฃ0.19 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ4.92 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.73 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ8.81 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.20 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-ยฃ6.05 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ6.93 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-ยฃ0.2 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA